porcin
reproduct
respiratori
syndrom
prr
one
signific
swine
diseas
worldwid
effici
prr
viru
prrsv
vaccin
would
invalu
minim
clinic
econom
impact
prrsv
infect
current
safe
effect
vaccin
protect
wide
varieti
strain
avail
zinc
zn
ion
salt
exhibit
broadspectrum
antivir
activ
varieti
virus
vitro
includ
anim
virus
equin
arter
viru
transmiss
gastroenter
viru
european
union
standard
dietari
zn
level
feedingstuff
limit
ppm
due
environment
reason
howev
countri
high
level
infe
zn
oxid
zno
ppm
may
ad
diet
pig
restrict
period
follow
wean
prevent
postwean
diarrhea
high
level
zno
proven
conserv
intestin
flora
critic
period
follow
chang
diet
place
wean
despit
effect
exact
mechan
zno
action
remain
uncertain
local
system
effect
zno
specif
viral
pathogen
also
remain
larg
unknown
evalu
system
effect
differ
zn
level
ad
convent
diet
contain
ppm
zn
znlow
control
group
prrsv
two
group
fed
diet
supplement
zno
final
concentr
ppm
zn
znmed
ppm
zn
znhigh
half
anim
receiv
singl
vaccin
experiment
uvinactiv
type
prrsv
lelystad
viru
lv
sinc
shown
similar
vaccin
viru
combin
suitabl
adjuv
could
strongli
prime
virusneutr
vn
respons
reduc
durat
viremia
homolog
challeng
contrast
vanhe
et
al
chose
singlevaccin
approach
challengeinfect
anim
heterolog
type
prrsv
sequenc
ident
envelop
glycoprotein
bear
major
neutral
epitop
order
test
influenc
elev
zn
level
suboptim
antigen
stimulu
crossprotect
studi
approv
local
anim
welfar
author
landesamt
gesundheit
und
sozial
berlin
germani
registr
number
g
german
landrac
piglet
n
sex
prrsvfree
herd
wean
age
day
move
biosafeti
level
experiment
facil
bundesinstitut
risikobewertung
berlin
germani
randomli
alloc
six
pen
n
per
pen
piglet
assign
three
differ
diet
pen
per
diet
age
day
anim
receiv
znhigh
diet
switch
znmed
diet
order
avoid
toxic
effect
zn
one
week
commenc
differ
diet
one
pen
per
diet
chosen
randomli
anim
vaccin
intramuscularli
inactiv
lv
access
kindli
provid
prof
h
nauwynck
ghent
univers
ghent
belgium
four
week
vaccin
age
day
pig
challeng
prrsv
field
strain
cresa
access
kindli
provid
prof
j
prof
e
mateu
cresa
barcelona
spain
anim
infect
intranas
applic
ml
viru
suspens
titer
nostril
use
spray
nebul
pig
monitor
daili
presenc
clinic
sign
bodi
weight
record
weekli
blood
sampl
collect
weekli
vaccin
day
post
infect
dpi
nasal
swab
taken
dpi
blood
sampl
quantif
viru
shed
pig
necropsi
day
pi
lung
lymphoid
tissu
evalu
visual
inspect
macroscop
lesion
sampl
lung
lymph
node
tonsil
spleen
taken
immedi
frozen
liquid
nitrogen
store
virolog
analysi
serum
sampl
dpi
nasal
swab
dpi
tonsil
lung
tracheobronchi
lymph
node
sampl
dpi
examin
qpcr
determin
prrsv
copi
number
rna
extract
perform
use
viral
rnadna
purif
kit
stratec
appli
serum
mg
tissu
rna
yield
qualiti
determin
spectrophotomet
nanodrop
technolog
revers
transcript
rt
perform
use
cdna
synthesi
kit
thermo
fisher
scientif
viral
load
quantifi
use
taqman
fluoresc
probebas
realtim
qpcr
assay
icycl
detect
system
biorad
primer
describ
elsewher
prrsvspecif
igm
igg
antibodi
measur
elisa
ingezim
prr
dr
ingenasa
accord
manufactur
instruct
vn
antibodi
prrsv
quantifi
viral
neutral
test
previous
describ
neutral
prrsv
strain
cresa
examin
use
prrsv
specif
monoclon
antibodi
ingenasa
alexa
conjug
antimous
igg
h
l
secondari
antibodi
invitrogen
peripher
blood
mononuclear
cell
pbmc
isol
use
densiti
centrifug
ficol
gradient
paa
laboratori
sampl
treat
erythrocyt
lysi
buffer
min
ice
pbmc
wash
ml
pb
bsa
centrifug
min
g
sampl
pbmc
viabil
confirm
use
standard
procedur
cellmedi
prrsvspecif
immun
respons
measur
use
elispot
enumer
ifngammasc
pbmc
mabtech
order
compar
homolog
heterolog
respons
pbmc
stimul
parallel
pbmcwell
well
per
pig
stimulu
cresa
lv
multipl
infect
unstimul
phastimul
cell
use
neg
posit
control
respect
ifngammasc
number
count
use
elispot
reader
system
aelvi
gmbh
flow
cytometri
analysi
perform
describ
use
bd
flow
cytomet
bd
bioscienc
data
analyz
softwar
treestar
data
set
support
result
articl
includ
within
articl
addit
file
